K-604

· Kowa Research Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for K-604, covering 2011-08-17 to 2011-08-17. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis [Phase 2]